Neurohormonal-cytokine interactions: Implications for inflammation, common human diseases and well-being

被引:216
作者
Elenkov, Ilia J. [1 ]
机构
[1] Italian Natl Res Council, Inst Neurobiol & Mol Med, I-00133 Rome, Italy
关键词
hormones; cytokines; Th1; cells; Th2; allergy; autoimmunity; depression; atherosclerosis;
D O I
10.1016/j.neuint.2007.06.037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neuroendocrine system affects the immune system through the neuroendocrine humoral outflow via the pituitary, and through direct neuronal influences via the sympathetic, parasympathetic (cholinergic) and peptidergic/sensory innervation of peripheral tissues. Circulating hormones or locally released neurotransmitters and neuropeptides regulate major immune functions, such as antigen presentation, antibody production, lymphocyte activity, proliferation and traffic, and the secretion of cytokines including the selection of T helper (Th)1 or Th2 cytokine responses. During inflammation, the activation of the stress system, through induction of a Th2 shift protects the organism from systemic "overshooting" with Th1/pro-inflammatory cytokines. Under certain conditions, however, stress hormones, substance P, ATP and the activation of the corticotropin-releasing hormone/substance P-histamine axis may actually facilitate inflammation, through induction of interleukin (IL)-1, IL-6, IL-8, IL-18, tumor necrosis factor (TNF)-alpha. and CRP production. Thus, a dysfunctional neuroendocrine-immune interface associated with abnormalities of the 'systemic anti-inflammatory feedback' and/or 'hyperactivity' of the local pro-inflammatory factors may play a role in the pathogenesis of atopic/allergic and autoimmune diseases, obesity, depression and atherosclerosis. Better understanding of the neuroendocrine control of inflammation may provide critical insights into mechanisms underlying a variety of common human immune-related diseases. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:40 / 51
页数:12
相关论文
共 127 条
[21]   PSYCHOLOGICAL STRESS AND SUSCEPTIBILITY TO THE COMMON COLD [J].
COHEN, S ;
TYRRELL, DAJ ;
SMITH, AP .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (09) :606-612
[22]  
Cole SW, 1998, J IMMUNOL, V161, P610
[23]   Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity [J].
Cole, SW ;
Naliboff, BD ;
Kemeny, ME ;
Griswold, MP ;
Fahey, JL ;
Zack, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (22) :12695-12700
[24]   REGULATION OF IGE PRODUCTION BY BETA(2)-ADRENOCEPTOR AGONISTS [J].
COQUERET, O ;
LAGENTE, V ;
FRERE, CP ;
BRAQUET, P ;
MENCIAHUERTA, JM .
CELLS AND CYTOKINES IN LUNG INFLAMMATION, 1994, 725 :44-49
[25]   Cytokines and depression: an analogic approach [J].
Corcos, M ;
Guilbaud, O ;
Hjalmarsson, L ;
Chambry, J ;
Jeammet, P .
BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (02) :105-110
[26]   Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: Failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis [J].
Crofford, LJ ;
Kalogeras, KT ;
Mastorakos, G ;
Magiakou, MA ;
Wells, J ;
Kanik, KS ;
Gold, PW ;
Chrousos, GP ;
Wilder, RL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (04) :1279-1283
[27]   THE ANTIINFLAMMATORY MECHANISM OF METHOTREXATE - INCREASED ADENOSINE RELEASE AT INFLAMED SITES DIMINISHES LEUKOCYTE ACCUMULATION IN AN IN-VIVO MODEL OF INFLAMMATION [J].
CRONSTEIN, BN ;
NAIME, D ;
OSTAD, E .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2675-2682
[28]  
CRONSTEIN BN, 1985, J IMMUNOL, V135, P1366
[29]  
DeKruyff R, 1998, J IMMUNOL, V160, P2231
[30]   Cytokine dysregulation, inflammation and well-being [J].
Elenkov, IJ ;
Iezzoni, DG ;
Daly, A ;
Harris, AG ;
Chrousos, GP .
NEUROIMMUNOMODULATION, 2005, 12 (05) :255-269